← Back to Search

Antiseptic

70% v/v Isopropyl Alcohol Surgical Solution for Surgical Site Infection

Phase 3
Waitlist Available
Led By Joseph P Hart, MD, FACS, DFSVS
Research Sponsored by Zurex Pharma, Inc.
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up within 30 days after surgery
Awards & highlights

Study Summary

Perioperative Patient Skin Antiseptic Preparation Evaluation

Eligible Conditions
  • Surgical Site Infection

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~within 30 days after surgery
This trial's timeline: 3 weeks for screening, Varies for treatment, and within 30 days after surgery for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Allergic Reaction and Skin Irritation
Surgical Site Infection Occurrence
Secondary outcome measures
Subgroup Analysis of Rates of Surgical Site Infections

Side effects data

From 2022 Phase 3 trial • 51 Patients • NCT04756804
4%
Endoleak
4%
Cardiac Distress
4%
Renal Distress
4%
Acute Blood Loss Anemia
4%
Chest Pain
4%
Pulmonary Distress
4%
Heart Failure Exacerbation
4%
Cerebral Hyperperfusion
4%
Altered Mental State
4%
Hypertension
100%
80%
60%
40%
20%
0%
Study treatment Arm
70% Isopropyl Alcohol Novel Preoperative Skin Antiseptic
2% Chlorhexidine Gluconate/70% Isopropyl Alcohol Preoperative Skin Antiseptic

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: 70% Isopropyl Alcohol novel preoperative skin antisepticExperimental Treatment1 Intervention
70% v/v Isopropyl Alcohol novel preoperative skin antisepsis preparation
Group II: 2% Chlorhexidine Gluconate/70% Isopropyl Alcohol preoperative skin antisepticActive Control1 Intervention
2% Chlorhexidine Gluconate/70% Isopropyl Alcohol preoperative skin antisepsis preparation
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
70% v/v Isopropyl Alcohol Surgical Solution
2021
Completed Phase 3
~60

Find a Location

Who is running the clinical trial?

Zurex Pharma, Inc.Lead Sponsor
8 Previous Clinical Trials
1,707 Total Patients Enrolled
Joseph P Hart, MD, FACS, DFSVSPrincipal InvestigatorMedical College of Wisconsin

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
clinicaltrials.govStudy
Perioperative Patient Skin Antiseptic Preparation Evaluation
2021. "Perioperative Patient Skin Antiseptic Preparation Evaluation". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT04756804.
~13 spots leftby May 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top